AI is reshaping how we detect diseases, develop treatments, and ensure AI safety. This week’s edition covers three key breakthroughs shaping 2025. This Edition’s Highlights: 👉 Mayo Clinic’s OmicsFootPrint: AI-powered disease mapping tool that visualizes molecular interactions and improves precision medicine. 👉 MIT’s MUNIS AI: A deep learning model transforming vaccine development by predicting immune responses with lab-level accuracy. 👉 Google’s AI Safety Framework: New guidelines addressing AI risks beyond pre-training, with implications for model transparency and safety. Read the newsletter to stay informed on how AI is reshaping healthcare and share your thoughts in the comments! ♻️ Repost if you find this helpful. About Us At ctcHealth, we combine pharmaceutical expertise and cutting-edge AI to transform healthcare sales. Our diverse team collaborates to create tailored solutions that meet today’s market demands. Follow to Learn More AI + Pharma Updates: 🔗 Follow us on LinkedIn: https://lnkd.in/ejUzK-Vd 🔔 Subscribe to our newsletter Pharma AI Weekly: https://lnkd.in/e8fzpbXi
ctcHealth’s Post
More from this author
-
Pharma AI Weekly #38: AI Predicts Preterm Birth Risk with 82% Accuracy, AI-Driven ECG Interpretation, and OpenAI Expands ‘Operator’ AI Agent
-
Pharma AI Weekly #37: Ex-DeepMind Scientist Launches Latent Labs, AI-Powered Self-Healing Electronic Skin, and AI for Robotic Knee Surgery
-
Pharma AI Weekly #36: Mayo Clinic’s OmicsFootPrint, MIT’s MUNIS AI, and Google’s New AI Safety Framework